These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15165507)

  • 1. An interview with Paul England, Ph.D., ProXara Biotechnology, Ltd. Interviewed by Vicki Glaser.
    England P
    Assay Drug Dev Technol; 2004 Apr; 2(2):115-20. PubMed ID: 15165507
    [No Abstract]   [Full Text] [Related]  

  • 2. An interview with Peter J. Coassin. Interview by Vicki Glaser.
    Coassin PJ
    Assay Drug Dev Technol; 2005 Apr; 3(2):125-31. PubMed ID: 15871687
    [No Abstract]   [Full Text] [Related]  

  • 3. Interview with Marc Ferrer, Ph.D.. Interview by Vicki Glaser.
    Ferrer M
    Assay Drug Dev Technol; 2010 Jun; 8(3):263-7. PubMed ID: 20589994
    [No Abstract]   [Full Text] [Related]  

  • 4. An interview with Doriano Fabbro, Ph.D., Novartis Biomedical Research Institute. Interviewed by Vicki Glaser.
    Fabbro D
    Assay Drug Dev Technol; 2004 Apr; 2(2):109-14. PubMed ID: 15165506
    [No Abstract]   [Full Text] [Related]  

  • 5. An interview with Steven M. Watkins, Ph.D., president and chief scientific officer, Lipomics Technologies, Inc. Interview by Vicki Glaser.
    Watkins SM
    Assay Drug Dev Technol; 2004 Aug; 2(4):339-43. PubMed ID: 15357914
    [No Abstract]   [Full Text] [Related]  

  • 6. Interview with Thomas P. Monath, M.D. Interview by Vicki Glaser.
    Monath TP
    Vector Borne Zoonotic Dis; 2005; 5(3):300-4. PubMed ID: 16187902
    [No Abstract]   [Full Text] [Related]  

  • 7. An interview with Martin Rosenberg, Ph.D. Interviewed by Vicki Glaser.
    Rosenberg M
    Assay Drug Dev Technol; 2009 Dec; 7(6):537-43. PubMed ID: 20035618
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of novel IVD assays: a manufacturer's perspective.
    Metcalfe TA
    Scand J Clin Lab Invest Suppl; 2010; 242():23-6. PubMed ID: 20515272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. David Urdal. Interview with Asher Mullard.
    Nat Rev Drug Discov; 2011 Oct; 10(11):806-7. PubMed ID: 22037031
    [No Abstract]   [Full Text] [Related]  

  • 10. Genesis IV--Fourth London Biotechnology Conference.
    Chan D
    IDrugs; 2005 Jan; 8(1):34-6. PubMed ID: 15650939
    [No Abstract]   [Full Text] [Related]  

  • 11. 2011 in reflection.
    Mullard A
    Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
    [No Abstract]   [Full Text] [Related]  

  • 12. Little biotech on the prairie.
    Wolfson W
    Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
    [No Abstract]   [Full Text] [Related]  

  • 13. Graduate Education in Pharmacology: Addressing the need for specialized training for pharmaceutical and biotechnology careers.
    Barrett JE; McGonigle P; Clark JE
    Pharmacol Res; 2016 Nov; 113(Pt A):327-331. PubMed ID: 27590782
    [No Abstract]   [Full Text] [Related]  

  • 14. An interview with Thomas Levelli. Interview by Vicki Glaser.
    Levelli T
    Assay Drug Dev Technol; 2005 Feb; 3(1):1-6. PubMed ID: 15798390
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy: cursed or inching towards credibility?
    Branca MA
    Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: between molecular and macroscopic protein engineering.
    Jungbauer A
    Biotechnol J; 2008 Feb; 3(2):143. PubMed ID: 18283675
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomas: battling side effects with physiotypes.
    McDonald J
    Yale J Biol Med; 2007 Dec; 80(4):187-90. PubMed ID: 18449393
    [No Abstract]   [Full Text] [Related]  

  • 18. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 19. An interview with Robert G. Lowery, PhD. by Vicki Glaser.
    Lowery RG
    Assay Drug Dev Technol; 2012 Feb; 10(1):1-4. PubMed ID: 22352940
    [No Abstract]   [Full Text] [Related]  

  • 20. An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser.
    Valenzano KJ
    Assay Drug Dev Technol; 2011 Jun; 9(3):191-7. PubMed ID: 21612548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.